Interview with Dr. Gary Wu: Studying bacterial metabolites may lead to new treatments for IBD
Dr. Gary D. Wu is a Professor in Gastroenterology at the University of Pennsylvania and currently Director and Chair of the Scientific Advisory Board for the American Gastroenterological Association Center for Gut Microbiome Research and Education.
Dr. Gary D. Wu is a Professor in Gastroenterology at the University of Pennsylvania and currently Director and Chair of the Scientific Advisory Board for the American Gastroenterological Association Center for Gut Microbiome Research and Education. His research examines interactions between gut microbiota and host, particularly focusing on diet and metabolism.
Dr. Wu gave a talk at Experimental Biology 2015 called, “Diet and the Intestinal Microbiome: Associations, Functions, and Implications for Health and Disease“.
Visit our Gut Microbiota for Health Youtube video channel for more expert interviews!
Also be sure to download our Gut Microbiota & Inflammatory Bowel Disease (IBD) Best of document.
Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014. Find her on: Google • Twitter
The gut and urogenital microbiota play a crucial role in the development and treatment of urogenital infections, revolutionizing the traditional perception of areas like the bladder, which were once considered sterile. This article explores how omics sciences are deepening our understanding of the human microbiota.
With the advancement of medicine, our population is undergoing a prolonged aging process. Over the next three decades, the global population aged over 65 years is set to more than double, reaching a staggering 1.5 billion individuals. The emergence of the gut microbiota as a potent modulator of healthy aging requires a concerted effort to allocate resources and research towards developing interventions aimed at promoting optimal gut health and longevity.
Patients with metabolic liver diseases may benefit from supplements of a common gut bacterium, a small study suggests.